	Neutrophil Extracellular Traps Are Not Linked to Decompensation, ACLF, or Death in Clinically Stable Patients With ACLD. Liver Int Balcar L, Scheiner B, Simbrunner B, Jachs M, Hartl L, Semmler G, Silvester Hofer B, Schwarz M, Dominik N, Adelmeijer J, Stättermayer AF, Pinter M, Trauner M, Quehenberger P, Francés R, Reiberger T, Lisman T, Mandorfer M. PMID: 40965468 [PubMed - indexed for MEDLINE]
	Managing MASLD Through Preventive Hepatology: Integrating Policy Reform, Public Health and Personalised Care. Liver Int Younossi ZM, Wong VW, Tsochatzis EA, Castera L, Betel M, Henry L, Sagi SZ. PMID: 40960268 [PubMed - indexed for MEDLINE]
	Evaluation of tri-ponderal mass index in predicting metabolic associated fatty liver disease in obese children. Pediatr Int Özer Y, Ulu E, Yurdakul Ertürk E. PMID: 40959930 [PubMed - indexed for MEDLINE]
	Comparative analysis of percutaneous aspiration and percutaneous catheter drainage for the treatment of liver abscess: A systematic review and meta-analysis. Medicine (Baltimore) Li XF, Pan DM. PMID: 40958348 [PubMed - indexed for MEDLINE]
	Revealing potential drug targets in liver dysfunction through proteome-wide Mendelian randomization. Medicine (Baltimore) Zhang XM, Yang T, Zeng YX, Yang X, Rao HT, Hu N, Xia GD. PMID: 40958295 [PubMed - indexed for MEDLINE]
	Global, regional, and national burden of nonalcoholic fatty liver disease (NAFLD) among people aged 15 to 49 years from 1990 to 2021, with projections to 2050: A systematic analysis based on the 2021 global burden of disease study. Medicine (Baltimore) Wang M, Wuyun Q, Lian D, Xu G, Zhu G, Zhang N. PMID: 40958266 [PubMed - indexed for MEDLINE]
	Screening for metabolic-associated fatty liver disease in type 2 diabetes patients using non-invasive scores and ultrasound: a cross-sectional study in Egypt. BMC Gastroenterol Semeya AA, Hafez RSAA, Ewais SHM, Mostafa SM, Eldeeb A, Elgamal R, Othman AAA. PMID: 40954485 [PubMed - indexed for MEDLINE]
	Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis. J Vis Exp Wood W, Pottorff A, Lazar L, Sathe M. PMID: 40952976 [PubMed - indexed for MEDLINE]
	Liver metabolic health and the components of metabolic syndrome in people living with HIV - do they differ from those in a 'healthy' population? HIV Res Clin Pract Bia, Czarnecki M, Inglot M. PMID: 40952717 [PubMed - indexed for MEDLINE]
	Association of pan-immune-inflammation value and atherogenic index of plasma with chronic coronary syndrome in non-alcoholic fatty liver disease patients. Front Endocrinol (Lausanne) Yu B, Zhao J, Zhang W, Wang L, Zheng X, Li X, Yao Z, Sun Y, Ren Z, Liang B. PMID: 40951434 [PubMed - indexed for MEDLINE]
	A new perspective on non-invasive diagnosis of non- alcoholic fatty liver disease: evidence integration of inflammatory and metabolic biomarkers based on a scoping review. Front Endocrinol (Lausanne) Liang H, Zhang D, Wei N, Xi P, Ge H, Zhang Y. PMID: 40951433 [PubMed - indexed for MEDLINE]
	Association of UHR and ECG parameters with type 2 diabetes mellitus in non-alcoholic fatty liver disease. Front Endocrinol (Lausanne) Wang Y, Liu M, Li W, Liu Y, Tang X, Sun F, Zhu H, Tang X. PMID: 40951422 [PubMed - indexed for MEDLINE]
	Cyclophilin D (PPIF) and MPTP in hepatic ischemia-reperfusion injury: insights into mechanisms. Front Immunol Liu J, Wu C, Lin Z, Ma M, Ma W, Yu X, Wang K, Zeng B. PMID: 40948767 [PubMed - indexed for MEDLINE]
	Endothelial Activation and Stress Index as a Novel Prognostic Marker in Intrahepatic Cholestasis of Pregnancy: A Case-Control Study. Am J Reprod Immunol Duygulu Bulan D, Dayanan R, Özkan MA, , Karabay G, Ça. PMID: 40948325 [PubMed - indexed for MEDLINE]
	Development of a water-soluble polarity/reactive nitrogen species dual-responsive fluorescence probe with enhanced specificity/sensitivity for early-stage non-alcoholic fatty liver disease diagnosis. Mikrochim Acta Wang H, Luo L, Han F, Peng S, Wang L, Shu X, Sun B, Liu Y, Zhang S, Yu Y. PMID: 40947469 [PubMed - indexed for MEDLINE]
	Secretory IgA Is a Key Marker Among Gut Barrier Dysfunction-Related Immunoglobulins Predicting Outcomes in ACLF. Liver Int Balogh B, Tornai D, Csillag A, Tornai I, Vitalis Z, Kovats P, Antal-Szalmas P, Dinya T, Laleman W, Coenraad MJ, Trebicka J, Papp M, MICROB. PMID: 40944472 [PubMed - indexed for MEDLINE]
	Gut Dysbiosis and Plasma Trimethylamine Oxide Are Associated with Subclinical Coronary Atherosclerosis in Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients Islam K, Kongsomboonchoke P, Chayanupatkul M, Tumkosit M, Chattranukulchai P, Prombutara P, Tangkijvanich P. PMID: 40944149 [PubMed - indexed for MEDLINE]
	MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression. Int J Mol Sci Asero C, Franzè MS, Cacciola I, Gangemi S. PMID: 40943552 [PubMed - indexed for MEDLINE]
	Endogenous Ethanol Metabolism and Development of MASLD-MASH. Int J Mol Sci Farràs Solé N, Wydh S, Alizadeh Bahmani AH, Bui TPN, Nieuwdorp M. PMID: 40943542 [PubMed - indexed for MEDLINE]
	Hepatic Histopathological Benefit, Microbial Cost: Oral Vancomycin Mitigates Non-Alcoholic Fatty Liver Disease While Disrupting the Cecal Microbiota. Int J Mol Sci Çirkin G, Aydemir S, Aç, Çelik A, Güler Y, Kiray M, Baykara B, Dinleyici EÇ, Öztürk Y. PMID: 40943536 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 71633

Page 1 of 3582



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy